Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
semaglutide clinical trials
12 selected ClinicalTrials.gov records carrying the official matched intervention semaglutide (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
12 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 108 selected PubMed records and 5 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT06778967
PeptideScanner retained ClinicalTrials.gov record NCT06778967 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was semaglutide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- November 10, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07743983
PeptideScanner retained ClinicalTrials.gov record NCT07743983 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was semaglutide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- October 13, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT07812597
PeptideScanner retained ClinicalTrials.gov record NCT07812597 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-10, and PeptideScanner's reviewed identity mapping was semaglutide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- September 10, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Semaglutide · 2026-11-10
ClinicalTrials.gov record NCT06778967
Completed at the retained observation.
Open attributed record →Semaglutide · 2026-10-19
ClinicalTrials.gov record NCT07879612
Not yet recruiting at the retained observation.
Open attributed record →Semaglutide · 2026-10-13
ClinicalTrials.gov record NCT07743983
Recruiting at the retained observation.
Open attributed record →Semaglutide · 2026-10-13
ClinicalTrials.gov record NCT07871799
Completed at the retained observation.
Open attributed record →Semaglutide · 2026-09-23
ClinicalTrials.gov record NCT07836140
Completed at the retained observation.
Open attributed record →Semaglutide · 2026-09-10
ClinicalTrials.gov record NCT07812597
Not yet recruiting at the retained observation.
Open attributed record →Semaglutide · 2026-07-21
ClinicalTrials.gov record NCT06975111
Recruiting at the retained observation.
Open attributed record →Semaglutide · 2025-01-08
ClinicalTrials.gov record NCT06764056
Not yet recruiting at the retained observation.
Open attributed record →Semaglutide · 2018-06-13
ClinicalTrials.gov record NCT02064348
Completed at the retained observation.
Open attributed record →Semaglutide · 2018-04-18
ClinicalTrials.gov record NCT02146079
Completed at the retained observation.
Open attributed record →Semaglutide · 2017-12-02
ClinicalTrials.gov record NCT02079870
Completed at the retained observation.
Open attributed record →Semaglutide · 2017-04-04
ClinicalTrials.gov record NCT02022254
Completed at the retained observation.
Open attributed record →